心脏再同步治疗方案对充血性心力衰竭的临床效果

The Clinical Effect of Cardiac Resynchronization Therapy in the Treatment of Congestive Heart Failure

目的:探讨心脏再同步治疗方案在充血性心力衰竭(CHF)患者治疗中的实施效果及对心功能、心律失常指标的影响。方法:选取佳木斯市中心医院2019年11月至2020年11月期间收治的52例CHF患者,按随机投掷法分为对照组和观察组,各26例。对照组实施米力农+酒石酸美托洛尔注射液治疗,观察组实施心脏再同步治疗方案,比较两组患者治疗效果及治疗前后心功能指标、心律失常指标变化情况。结果:治疗前两组患者的左心室短轴缩短率(LVFS)、左心室射血分数(LVEF)、每搏输出量(SV)比较,差异无统计学意义(P>0.05)。治疗后观察组患者的LVFS、LVEF、SV均高于对照组,差异具有统计学意义(P<0.05);治疗前两组患者的阵发性房性心动过速、阵发性心房颤动及QRS时限比较,差异无统计学意义(P>0.05)。治疗后观察组患者的阵发性房性心动过速、阵发性心房颤动及QRS时限均低于对照组,差异具有统计学意义(P<0.05)。结论:心脏再同步治疗方案用于CHF患者治疗中的效果显著。

Objective To explore the effect of cardiac resynchronization therapy in patients with congestive heart failure (CHF) and its impact on cardiac function and arrhythmia indicators.Methods A total of 52 CHF patients admitted to Jiamusi Central Hospital from November 2019 to November 2020 were selected and divided into a control group and an observation group according to the random throw method,with 26 cases in each group.The control group was treated with milrinone + metoprolol tartrate injection,and the observation group was treated with a cardiac resynchronization treatment plan.The treatment effects and changes of cardiac function indexes and arrhythmia indexes before and after treatment were compared between the two groups.Results Before treatment,there were no significant difference in left ventricular fractional shortening (LVFS),left ventricular ejection fraction (LVEF),and stroke volume (SV) between the two groups of patients (P > 0.05).After treatment,the LVFS,LVEF,and SV of the observation group were higher than those of the control group,and the difference was statistically significant (P < 0.05);Before treatment,there was no difference in paroxysmal atrial tachycardia,paroxysmal atrial fibrillation and QRS time limit between the two groups of patients statistical significance (P > 0.05).After treatment,the duration of paroxysmal atrial tachycardia,paroxysmal atrial fibrillation and QRS of the observation group were lower than those of the control group,and the difference was statistically significant (P < 0.05).Conclusion Cardiac resynchronization therapy has a significant effect in the treatment of CHF patients.